SCHEMBL9976530

SCHEMBL9976530

NCc1cc(-c2ccc(I)s2)sc1-c1ccc(-c2sc(-c3ccc(I)s3)cc2CN)s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9976547 0.78 AKR1B1 (0.33)
SCHEMBL9976572 0.77 LTA4H (0.42)
SCHEMBL15672434 0.75 KDM4E (0.40)
SCHEMBL9976553 0.75 LTA4H (0.53)
SCHEMBL9976543 0.74 KDM4E (0.42)
SCHEMBL9976578 0.73 ACACA (0.33)
SCHEMBL498510 0.72 APP (0.33)
SCHEMBL21156754 0.72 APP (0.33)
SCHEMBL24597091 0.71 DPP4 (0.47)
SCHEMBL9976540 0.70 LTA4H (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8710246-B2 Substituted thiophene pentamers BIOCHROMIX NEWCO AB (SE) 2014-04-29 US disclosed
US-8710246-B2 Substituted thiophene pentamers BIOCHROMIX NEWCO AB (SE) 2014-04-29 US disclosed
US-20120157516-A1 NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPY BIOCHROMIX PHARMA AB 2012-06-21 US disclosed
US-20120157516-A1 NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPY BIOCHROMIX PHARMA AB 2012-06-21 US disclosed
WO-2010044744-A1 NOVEL THIOPHENE COMPOUNDS FOR IN VIVO IMAGING BIOCHROMIX AB (SE) 2010-04-22 WO disclosed
WO-2010044743-A1 NOVEL THIOPHENE COMPOUNDS FOR USE IN THERAPHY BIOCHROMIX PHARMA AB (SE) 2010-04-22 WO disclosed